Bellomo Rinaldo, Reade Michael C, Warrillow Stephen J
Department of Intensive Care, Austin Hospital, Studley Rd, Heidelberg, Victoria 3084, Australia.
Crit Care. 2008;12(2):130. doi: 10.1186/cc6841. Epub 2008 Apr 7.
In this issue of Critical Care, Dutch investigators report that, in a cohort of patients with sepsis/septic shock admitted to three different intensive care units (ICUs), low central venous oxygen saturation (ScvO2) was uncommon at the time of ICU admission, and hospital mortality was <30%. Their findings, taken together with those of recent reports from Australia and New Zealand (ANZ), raise serious concerns about the utility of early goal directed therapy (EGDT) outside the context of the original trial. Despite inclusion of EGDT into the Surviving Sepsis Guidelines, in response to growing uncertainty, ANZ and US investigators will soon begin randomization of patients into two large multicentre trials comparing EGDT to standard therapy. Until such studies are completed, basing international treatment guidelines on a single centre study performed in what may turn out to be a highly atypical environment would seem premature.
在本期《重症监护》杂志中,荷兰研究人员报告称,在入住三个不同重症监护病房(ICU)的脓毒症/脓毒性休克患者队列中,入住ICU时中心静脉血氧饱和度(ScvO2)较低的情况并不常见,且医院死亡率<30%。他们的研究结果,与澳大利亚和新西兰(ANZ)近期报告的结果相结合,引发了对于在原始试验背景之外早期目标导向治疗(EGDT)效用的严重担忧。尽管EGDT已被纳入《拯救脓毒症指南》,但鉴于不确定性不断增加,ANZ和美国研究人员将很快开始把患者随机分为两项大型多中心试验,比较EGDT与标准治疗。在这些研究完成之前,基于可能是高度非典型环境下进行的单中心研究制定国际治疗指南似乎为时过早。